Ceo
CurrentEniware LLC is a unique company launched to change the face of health care in the developing world, disaster relief work and in militaries throughout the world with cutting edge room temperature sterilization technology. Led by Dr. James Bernstein, a successful serial entrepreneur and Founder of Noxilizer, Eniware has been established as a spin out of Noxilizer, Inc., and has secured an exclusive proprietary license to Noxilizer, Inc.’s patented nitrogen dioxide (NO2) gas sterilization technology for Africa, Asia (except Japan), and the Middle East, as well as a global license to develop portable sterilization solutions for military and disaster relief applications. Infection and disease transmission in clinics and hospitals afflict millions in the developing world. There is no satisfactory, effective non-electricity dependent sterilization available today. The Noxilizer nitrogen dioxide sterilization technology has significant competitive advantages over existing sterilization technologies: independence from electricity and other infrastructure, low cost, rapid gas package penetration and aeration, better material compatibility, and reduced residue after sterilization. . Eniware intends to provide portable, power-free, low temperature, low-cost sterilization of medical instruments in low-resource settings.The company is focused on generating near-term revenue by rapidly developing and commercializing portable sterilization units for all licensed markets while seeking additional support from global health organizations such as the WHO, Doctors Without Borders (MSF), and the Red Cross, as well as working with academic institutions and the U.S. Department of Defense.Eniware’s key members of management are all seasoned executives and entrepreneurs.The organization is structured to function efficiently and to leverage the expertise of key advisors, providing the Company with interdisciplinary breadth and depth needed to develop the Eniware technology.